“As a result of the Company’s 2026 debt-related activity, anticipated annual interest expense is expected to decrease approximately $1 million.”10-Q · Aug 5, 2026 ↗
The Chemours Company
CC
Market read
The Chemours Company's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 22 directly disclosed connections are confirming.
- Lower volumes in TSS and APM were offset by higher prices in TSS and TT. Compare whether volume declines persist and whether price offsets remain disclosed.
Invalidation: The isolated read changes if CC's group or a disclosed connection begins moving with it.
Research brief
The story so far
No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 22 directly disclosed connections are confirming.
No thresholded supportive filing evidence is available yet.
No thresholded adverse filing evidence is available yet.
- Lower volumes in TSS and APM were offset by higher prices in TSS and TT. Compare whether volume declines persist and whether price offsets remain disclosed.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Credit and interest rates has repeated favorable evidence across 5 filings.
- Net margin changed -7.8 percentage points in the latest annual period.
- Demand and volume has repeated adverse evidence across 5 filings.
- Input and raw-material costs has repeated adverse evidence across 5 filings.
- Supply chain and availability has repeated adverse evidence across 4 filings.
- EV/sales is 41% above the available filing-peer median; determine whether growth and quality justify the difference.
Price as of Sep 11, 2026
15.04Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
“This action was taken due to regulatory changes and uncertainty that have caused reduced demand and market deselection of telomer-based chemistries, making SPS economically unfavorable going forward.”10-Q · Aug 5, 2026 ↗
“The decreases in segment Adjusted EBITDA and Adjusted EBITDA margin for the six months ended June 30, 2026 were primarily attributable to lower costs absorption as a result of lower volumes and higher input costs, partially offset by favorable currency moveme…”10-Q · Aug 5, 2026 ↗
“These were partially offset by a $ 66 tax benefit related to environmental and litigation reserve, both recorded during the quarter.”10-Q · Aug 5, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 0.4× · EV/sales 1.0×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for CC. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for CC. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind CC
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
DDDuPont de Nemours, Inc.supplierMay 5, 2026 ▾
“In March 2025, the Alabama Supreme Court granted the mandamus and directed the case against DuPont and the other supplier defendants to be dismissed on failure to timely file within the statute of limitations.”
CHCOCity Holding CompanysupplierMay 5, 2026 ▾
“In August 2023, the Water Works and Sewer Board of the City of Gadsden, Alabama also filed suit in Alabama state court against the Company, DuPont, Corteva and other suppliers to carpet mills in Dalton Georgia, as well as against various landfill and waste co…”
Depended on by
CTVACorteva, Inc.supplierFeb 12, 2026 ▾
“The company, pursuant to the respective Separation Agreements, is entitled to cost sharing and indemnification from The Chemours Company ("Chemours"), Dow and DuPont, as applicable, for certain litigation, environmental, workers’ compensation and other liabil…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 20 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
CC is currently a Leader in the organic co-movement group Specialty Chemicals. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for CC; it is not active in the latest market snapshot.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.